1993
DOI: 10.1159/000201078
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Pancreatic Ascites and External Pancreatic Fistulas with a Long-Acting Somatostatin Analogue (Sandostatin)

Abstract: Prior to the advent of somatostatin conservative therapy for pancreatic fistulas, treatment included intravenous nutritional therapy with nothing per mouth and therapeutic agents to diminish pancreatic secretions. None of these modalities were uniformly successful. A prospective study to evaluate the efficacy of a long-acting somatostatin analogue (Sandostatin) was carried out. 18 patients – 10 with pancreatic ascites and 8 with external pancreatic fistulas -were treated. The ascites resolved in 9 of 10 patien… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
19
0

Year Published

1995
1995
2009
2009

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(20 citation statements)
references
References 8 publications
(13 reference statements)
1
19
0
Order By: Relevance
“…External pancreatic fistulas occurred after abdominal trauma, surgery to the pancreas, following catheter drainage of pseudocysts or as a complication of acute pancreatitis. Spontaneous closure was unusual, but octreotide therapy was highly efficacious, often achieving closure by 3 days; occasionally total parenteral nutrition was used as an adjuvant measure [18]. This experience concurs with that of others [19,20].…”
supporting
confidence: 84%
“…External pancreatic fistulas occurred after abdominal trauma, surgery to the pancreas, following catheter drainage of pseudocysts or as a complication of acute pancreatitis. Spontaneous closure was unusual, but octreotide therapy was highly efficacious, often achieving closure by 3 days; occasionally total parenteral nutrition was used as an adjuvant measure [18]. This experience concurs with that of others [19,20].…”
supporting
confidence: 84%
“…PD stents work by bypassing the pancreatic sphincter, thereby converting the normally high-pressure pancreatic ducts to a low pressure system with preferential flow through the stent, and thus facilitating spontaneous healing of the disruption site. [15][16][17] Management of PPF in the initial stages relies on optimization of fluid and electrolyte imbalance at presentation and is of paramount importance. These patients are usually malnourished at presentation and may have additional sodium bicarbonate deficiency due to large volume loss of pancreatic exocrine secretions.…”
Section: Discussionmentioning
confidence: 99%
“…Initial treatment is conservative comprising nil by mouth, somatostatin analogue administration, abdominal drainage (or repeated paracentesis), insertion of a chest drain (or repeated thoracocentesis) and total parenteral nutrition or enteral nutrition distal to the ligament of Treitz, following which a substantial number (50–65%) of fistulae will close [103, 104, 105]. If conservative treatment fails, the next therapeutic option is endoscopic pancreatic stenting and although the data are mainly from case reports and very small series, the results are promising with success rates of up to 100% [55, 97, 106, 107, 108, 109, 110, 111](table 8).…”
Section: Internal Pancreatic Fistulae and Pancreatic Ascitesmentioning
confidence: 99%